“Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s636. doi:10.25251/57ey8s02.